Immunovant, Inc.

NASDAQ:IMVT

25.86 (USD) • At close December 20, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 001.50000000000000000.9260000000
Kosten van de omzet 00.080.0640.0580.3490.3430.3410.3330.3270.3230.3140.3130.3050.30.2410000.46300.3950.0680000
Brutowinst 0-0.081.436-0.058-0.349-0.343-0.341-0.333-0.327-0.323-0.314-0.313-0.305-0.3-0.2410000.4630-0.395-0.0680000
Brutowinstmarge 000.9570000000000000000.50000000
Onderzoek- en ontwikkelingskosten 97.27275.47366.05648.33847.95950.57551.83742.25237.73928.42931.98629.75621.36118.70518.61521.09111.97616.92214.1684.95310.33118.4767.977.6835.7454.335
Algemene en administratieve kosten 18.47118.80814.82313.21513.84115.40212.42211.77511.87511.94615.24111.51516.28911.18110.30210.5498.9989.6646.3156.0884.1631.5850.9631.2010.4950.033
Verkoop- en marketingkosten 0-0.08-0.06400000000000000000000000
Verkoop-, algemene en administratieve kosten 18.47118.72814.75913.21513.84115.40212.42211.77511.87511.94615.24111.51516.28911.18110.30210.5498.9989.6646.3156.0884.1631.5850.9631.2010.4950.033
Overige kosten 00.028-2.5871.0940.020.4640.356-1.7570.7930.3540.044-0.114-0.084-0.6260.68-0.5030.225-0.074-0.1270.2210.420.0920000
Bedrijfskosten 115.74394.20180.81561.55361.865.97764.25954.02749.61440.37547.22741.27137.6529.88628.91731.6420.97426.58620.48311.0410.420.09208.8416.3464.368
Bedrijfsresultaat -115.743-94.281-80.879-51.526-58.208-73.948-64.313-44.027-49.614-40.375-47.266-41.385-37.65-29.886-28.917-31.64-20.974-26.586-20.483-11.041-0.42-0.092-0-8.884-6.24-4.368
Bedrijfsresultaat ratio 00-53.919000000000000000-22.1250000000
Totaal overige inkomsten en kosten netto 6.7027.2085.79210.0273.5924.52913.836-8.8131.9470.3540.044-0.114-0.084-0.6260.68-0.5030.225-0.074-0.127-0.1550.6830.34200.043-0.106-0
Inkomen voor belasting -109.041-87.073-75.087-51.526-58.208-73.948-60.423-62.84-47.667-40.021-47.183-41.385-37.734-30.512-28.237-32.143-20.749-26.66-20.61-11.1960.2630.249-0-8.841-6.346-4.368
Inkomen voor belasting ratio 00-50.058000000000000000-22.2620000000
Belastingkosten 0.0780.0770.232-0.1080.454-0.011-0.9920.3870.2610.352-0.012-0.28-0.031-0.041-0.079-0.3670.040.048-0.0590.10.1380.0660.0070.0080.004-0
Nettowinst -109.119-87.15-75.319-51.418-58.662-73.937-59.431-63.227-47.928-40.373-47.171-41.385-37.703-30.471-28.158-31.776-20.789-26.708-20.551-11.2960.1250.183-0-8.849-6.35-4.368
Nettowinstmarge 00-50.213000000000000000-22.1980000000
WPA (Winst Per Aandeel) -0.74-0.6-0.52-0.36-0.45-0.57-0.46-0.49-0.41-0.35-0.41-0.36-0.35-0.31-0.29-0.32-0.21-0.32-0.29-0.280.0440.0160-0.24-0.36-0.44
Verwaterde WPA -0.74-0.6-0.52-0.36-0.45-0.57-0.46-0.49-0.41-0.35-0.41-0.36-0.35-0.31-0.29-0.32-0.21-0.32-0.29-0.280.0090.064-0-0.24-0.36-0.44
EBITDA -115.654-94.201-80.815-61.495-61.744-65.924-64.205-53.978-49.568-40.331-47.188-41.238-37.429-29.86-28.28-31.621-20.96-26.576-20.604-10.82-0.42-0.092-0-8.88300
EBITDA ratio 00-53.877000000000000000-22.2550000000